[{"Assets_0_Q1_USD":1572091000.0,"CommonStockSharesConverted_0_Q1_shares":103740000.0,"EarningsPerShareBasic_1_Q1_USD":0.78,"EarningsPerShareDiluted_1_Q1_USD":0.77,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":31274000.0,"NetIncomeLossConverted_1_Q1_USD":69058000.0,"RevenuesConverted_1_Q1_USD":462021000.0,"StockholdersEquity_0_Q1_USD":-74090000.0,"StockholdersEquityConverted_0_Q1_USD":-73912000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":89994000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":88117000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20170428"}]